 |
3 Products |  |
4 Diseases | | 3 Products |
|
4 Trials |  |
130 News |  |
| «12 |
- || prexigebersen (BP1001) - Bio / Path
Enrollment change: Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS (clinicaltrials.gov) - Apr 13, 2015
P1, N=60, Recruiting, Sponsor: Bio-Path Holdings, Inc.
N=18 --> 60